Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration

BACKGROUND: Mitomycin C (MMC) is an antitumor agent that is often administered intravesically to treat bladder cancer. Pharmacologically optimized studies have suggested varying methods to optimize delivery, with drug concentration and solution volume being the main drivers. However, these MMC conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, Alan L., Zhang, Yan-Ping, Kawedia, Jitesh D., Zhou, Ximin, Sobocinski, Stacey M., Metcalfe, Michael J., Kramer, Mark A., Dinney, Colin P. N., Kamat, Ashish M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427054/
https://www.ncbi.nlm.nih.gov/pubmed/28470465
http://dx.doi.org/10.1007/s40268-017-0183-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427054/
https://www.ncbi.nlm.nih.gov/pubmed/28470465
http://dx.doi.org/10.1007/s40268-017-0183-y

Ejemplares similares